SCHEMBL4722865

SCHEMBL4722865

CO/N=C(\N)c1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 11/20 0.54
RAB9A P51151 11/20 0.54
CDK5 Q00535 1/20 0.54
CDK5R1 Q15078 1/20 0.54
KMT2A Q03164 2/20 0.50
MEN1 O00255 1/20 0.50
SMN1; SMN2 Q16637 6/20 0.49
PKM P14618 6/20 0.49
MAPT P10636 3/20 0.49
TNF P01375 1/20 0.49
KLF5 Q13887 1/20 0.49
NOD1 Q9Y239 1/20 0.49
HPGD P15428 4/20 0.47
NFKB1 P19838 3/20 0.47
NFKB2 Q00653 3/20 0.47
RELA Q04206 3/20 0.47
GAA P10253 2/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
POLB P06746 1/20 0.47
ALDH1A1 P00352 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4722868 1.00 NPC1 (0.54) NPC1RAB9ACDK5CDK5R1KMT2A
SCHEMBL8974042 0.82 NPC1 (0.42) NPC1RAB9ACDK5CDK5R1KMT2A
SCHEMBL14902858 0.80 SMN1; SMN2 (0.54) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL13882951 0.80 SMN1; SMN2 (0.54) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL6650000 0.80 MASP2 (0.43) NPC1RAB9ACDK5CDK5R1KMT2A
SCHEMBL5182946 0.78 NPC1 (0.37) NPC1RAB9ACDK5CDK5R1KMT2A
SCHEMBL5182951 0.78 NPC1 (0.37) NPC1RAB9ACDK5CDK5R1KMT2A
SCHEMBL6007355 0.78 NPC1 (0.58) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL18315099 0.78 RAB9A (0.60) NPC1RAB9AKMT2AMEN1SMN1; SMN2
SCHEMBL23901725 0.77 L3MBTL1 (0.49) NPC1RAB9ACDK5CDK5R1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080319206-A1 Process for Preparing Protected Amidines ASTRAZENECA AB (SE) 2008-12-25 US disclosed
EP-1856035-B1 PROCESS FOR PREPARAING PROTECTED AMIIDINES ASTRAZENECA AB (SE) 2008-12-10 EP disclosed
EP-1856035-A1 PROCESS FOR PREPARAING PROTECTED AMIIDINES AstraZeneca AB (SE) 2007-11-21 EP disclosed
WO-2006090153-A1 PROCESS FOR PREPARING PROTECTED AMIIDINES ASTRAZENECA AB (SE) 2006-08-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080319206-A1 Process for Preparing Protected Amidines HK1, HRH4, PYM1 NPC1 1528/4885RAB9A 1272/4885CDK5 1945/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.